Valo Therapeutics Company
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Technology:
Cell-based gene therapy, Viral Vectors
Industry:
Covid-19, Private
Headquarters:
Helsinki, Southern Finland, Finland
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
2
Total Funding:
11601987
Estimated Revenue:
$10M to $50M
Last Funding Date:
2023-02-14
Last Funding Type:
Grant
Register and Claim Ownership